<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12">
 <label>12</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Giusti</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Mazzotta</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Filetti</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Marinelli</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Di Napoli</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Scarpino</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>CDKN2A/B gene loss and MDM2 alteration as a potential molecular signature for hyperprogressive disease in advanced NSCLC: A next-generation-sequencing approach</article-title>. 
  <source>JCO</source> (
  <year>2019</year>) 
  <volume>37</volume>:
  <page-range>e20628–8</page-range>.  
  <pub-id pub-id-type="doi">10.1200/JCO.2019.37.15_suppl.e20628</pub-id>
 </mixed-citation>
</ref>
